Clinical Trial

Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.

Study acronym: NITOutcomes
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Primary objective is to study the relevance of non-invasive test (NITs) in predicting disease stage (diagnostic biomarker) and outcome (predictive biomarker) in patients with suspected or established liver disease and cirrhosis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-03-28.
Trial Details
NCT Number NCT05312853
Lead Sponsor Johannes Gutenberg University Mainz
Collaborators: Boehringer Ingelheim, Nordic Bioscience A/S
Conditions Chronic Liver Disease
Enrollment 250 participants
Start Date 2024-01-15
Primary Completion 2034-04-15 (estimated)
Study Completion 2034-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-01-03